C92-75664-90811
4 vaccinations
9 coded responses
23 check-ins
9 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 337 / FL
- Registered
- 2021-01-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-03
Dose 1 — Moderna
-
2021-01-15
Registered in v-safe
- 2021-01-15
- 2021-01-17
- 2021-01-24
-
2021-01-26
Dose 2 — Moderna
-
2021-01-31
Survey response — days 1–6 daily, dose 2MedDRA: Adverse reaction — Feeling: Good · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessFree text: The above symptoms were present up until 3 days post vaccination but not now (x5 days post-v)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-01
- 2021-02-02
- 2021-02-09
-
2021-02-16
Survey response — day 21, dose 2MedDRA: Tinnitus — Feeling: GoodFree text: Increased TinnitusMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-25
Survey response — day 28, dose 2MedDRA: Pre-existing disease, Tinnitus — Feeling: GoodFree text: Continued increase in TinnitusMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-02
Survey response — day 35, dose 2MedDRA: Pre-existing disease, Tinnitus — Feeling: GoodFree text: Continuing increase in TinnitusMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-10
Survey response — day 42, dose 2MedDRA: Tinnitus — Feeling: GoodFree text: Persistent TinnitusMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-27
Survey response — 3 months, dose 2MedDRA: Tinnitus — Feeling: GoodFree text: Continued post-vaccine increased levels of TinnitusMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-28
-
2021-10-25
Dose 3 — ModernaCo-administered: Flu
-
2022-01-28
Survey response — 12 months, dose 2MedDRA: Arthralgia, Tinnitus — Feeling: GoodFree text: Continued increased intensity of Tinnitus. Persistant and increased level of hip and knee joint pain - both post vaccine effects.MedDRA releases: 2024-11 · check-in free text available
-
2022-01-28
Survey response — 3 months, dose 3MedDRA: Arthralgia, Pre-existing disease, Tinnitus — Feeling: GoodFree text: Increased intensity of Tinnitus and increased frequency and intensity of joint (knee and hip) painMedDRA releases: 2024-11 · check-in free text available
-
2022-04-23
Dose 4 — Moderna
- 2022-04-25
-
2022-05-18
Survey response — day 21, dose 4MedDRA: Arthralgia, Tinnitus — Feeling: GoodFree text: Increased level of Tinnitus; Increased joint pain - hipMedDRA releases: 2024-11 · check-in free text available
- 2022-05-23
- 2022-05-28
- 2022-06-06
- 2022-07-25
- 2022-10-24
- 2023-04-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-03 | Moderna | |
| 2 | 2021-01-26 | Moderna | |
| 3 | 2021-10-25 | Moderna | Flu |
| 4 | 2022-04-23 | Moderna | No |
Free text
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): The above symptoms were present up until 3 days post vaccination but not now (x5 days post-v)
Release 4 — day 21, dose 2
Symptoms: Increased Tinnitus
Release 4 — day 28, dose 2
Symptoms: Continued increase in Tinnitus
Release 4 — day 35, dose 2
Symptoms: Continuing increase in Tinnitus
Release 5 — day 42, dose 2
Symptoms: Persistent Tinnitus
Release 8 — 3 months, dose 2
Symptoms: Continued post-vaccine increased levels of Tinnitus
Release 11 — 3 months, dose 3
Symptoms: Increased intensity of Tinnitus and increased frequency and intensity of joint (knee and hip) pain
Release 11 — 12 months, dose 2
Symptoms: Continued increased intensity of Tinnitus. Persistant and increased level of hip and knee joint pain - both post vaccine effects.
Release 11 — day 21, dose 4
Symptoms: Increased level of Tinnitus; Increased joint pain - hip
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | · | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Tinnitus | ✓ | ✓ | ✓ |
| SRO | Adverse reaction | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release